HK Stock Market Move | RIMAG GROUP (02522) rose more than 8% during trading, and the company plans to further increase its stake in Yinged Medical Veins. It is scheduled to hold a strategic upgrade conference tomorrow.

RIMAG GROUP (02522) rose more than 8% in intra-day trading, reaching a 6.7% increase as of the time of writing, at 8.44 Hong Kong dollars, with a turnover of 18.4711 million Hong Kong dollars. On the news front, RIMAG GROUP plans to invest about HK$353 million to further increase its stake in He Medical Pulse, with the total shareholding percentage reaching 25.36%. This acquisition is a key move for the group to move from project incubation to strategic heavy holdings, and also to improve the core measures of the "data model-scenario" tripartite strategic layout and firmly consolidate the underlying capabilities of AI technology, serving as a key action for RIMAG GROUP to achieve global smart imaging + ecological layout and strategic value upgrade, fully in line with the group's long-term development plan in the field of medical imaging. It is worth noting that, according to a message from RIMAG GROUP's official WeChat account, the company will hold a strategic upgrade and global smart imaging + ecological conference on April 28, where the conference will release a mysterious smart imaging twin product, a super smart brain CT system, and an imaging AI super factory intelligent manufacturing system. RIMAG GROUP stated that as China's leading third-party medical imaging service provider, the company will reach a key strategic upgrade milestone in 2026.